Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether interferon-beta impairs the ability of
plasmacytoid dendritic cells to promote pathogenic immune responses in patients with multiple
sclerosis.